Abstract:Genetic susceptibility seems to play an important role in some gastric cancers. In some rare cases, gastric cancer can be one part of familial cancer syndromes. A well-known example is the family of Napoleon since the Emperor himself as well as his father and his grandfather had gastric cancer. Generally, hereditary factors include germline mutations of E-cadherin, APC, p53 or mismatch repair genes like hMLH1 or hMSH2. Gatekeeper genes like Ecadherin and APC encode signaling proteins important to cellular proliferation and differentiation while protein products from caretaker genes like p53 or mismatch repair genes are important to maintain the integrality and fidelity of the genome. In addition to gene mutations, gene polymorphisms have been shown to be associated with the susceptibility of gastric cancer (El-Omar et al., 2000; Persson et al., 2011). Interestingly, most of these genes are encoding proinflammatory cytokines, strongly indicating the importance of inflammation to the initiation and progression of gastric cancer. Environment factors play important roles in the pathogenesis of gastric cancer by affecting the inflammation in the stomach. The infection of Helicobacter pylori is apparently one of the primary risk factors of gastric cancer. In 1994, the World Health Organization and the International Agency for Research on Cancer Consensus group classified H. pylori as a type I carcinogen in human beings. Although numerous studies reported the growth promoting effect of H. pylori or its derived proteins in vitro, no direct evidence about the interaction of H. pylori with cancer initiating or stem cells have been presented. In contrast, accumulating reports indicated that the inflammation induced by H. pylori infection is the key to gastric carcinogenesis. Thus, it was believed that H. pylori infection is the initial step in the stepwise process of gastric carcinogenesis starting from chronic gastritis, gastric atrophy, intestinal metaplasia, dysplasia to gastric carcinoma. Consistently, diets rich in fruit and vegetables is protective factors of gastric cancer since vitamin C are helpful to attenuate inflammation while inflammation-promoting factors such as smoking, foods with high salts and nitrite could facilitate the development of gastric cancer by promoting chronic inflammation. Microenvironments in chronic inflammatory tissues are rich in growth factors and cytokines important to promote the perpetuation of tumor growth by epigenetically reprogramming cancer stem cells. In addition, there are some DNA damage inducing agents such as reactive oxygen and nitrogen species (RONS) that can cause genomic alterations, promoting the accumulation of mutations in proliferating cancer stem cells (Meira et al., 2008). On the other

Gastric Cancer: an Epigenetic View

Methylation Modification In Gastric Cancer And Approaches To Targeted Epigenetic Therapy

Epigenetics on Gastric Cancer Research

Gastric Cancer in the Era of Epigenetics

Epigenetic Regulation of DNA Methylation and RNA Interference in Gastric Cancer: A 2024 Update

Epigenetic Deregulations in Gastric Cancer

Epigenetic Biomarkers: Potential Applications in Gastrointestinal Cancers.

Emerging Molecular Classifications and Therapeutic Implications for Gastric Cancer

Pathogenetic Mechanisms in Gastric Cancer

Epigenetic roles in the malignant transformation of gastric mucosal cells

Epigenetic Variation Analysis Leads to Biomarker Discovery in Gastric Adenocarcinoma

Recent Progress in the Study of Methylated Tumor Suppressor Genes in Gastric Cancer

Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification

Epigenetics of Gastric Cancer

Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis

Recent Progress in Genetic and Epigenetic Profile of Diffuse Gastric Cancer

The Epigenetic Aspects of Gastric Cancer

Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives

Epigenetic Regulation of Long Non-Coding RNAs in Gastric Cancer

DNA Methylation Drives a New Path in Gastric Cancer Early Detection: Current Impact and Prospects

Gastric cancer treatment: recent progress and future perspectives